Related Experiment Video

Updated: May 17, 2026

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library
08:40

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library

Published on: April 6, 2012

MiR-210 disturbs mitotic progression through regulating a group of mitosis-related genes

Jie He1, Jiangbin Wu, Naihan Xu

  • 1School of Life Sciences, Tsinghua University, Beijing 100084, PR China.

Nucleic Acids Research
|November 6, 2012
PubMed

Insights

MicroRNA-210 (miR-210) disrupts mitosis by targeting key cell cycle genes. This finding suggests miR-210 may inhibit tumor formation, offering potential therapeutic insights.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Genetics

Background:

  • MicroRNA-210 (miR-210) is frequently upregulated in various cancers.
  • The precise function of miR-210 in cancer remains unclear and requires further investigation.

Purpose of the Study:

  • To elucidate the molecular mechanisms and biological consequences of miR-210 in cell cycle regulation, specifically focusing on mitosis.
  • To identify and validate miR-210 target genes involved in mitotic progression.

Main Methods:

  • Bioinformatic analysis to identify putative miR-210 target genes in hypoxia-induced CNE cells.
  • Experimental validation of miR-210 targeting of specific mitosis-related genes (Plk1, Cdc25B, Cyclin F, Bub1B, Fam83D) via their 3'-UTRs.
  • Assessment of miR-210's impact on mitotic progression and tumor formation in a mouse model.

Main Results:

  • Two major functional gene groups, cell cycle and RNA processing, were identified as miR-210 targets.
  • Hypoxia-induced miR-210 upregulation correlated with downregulation of several key mitosis genes.
  • Overexpression of miR-210 led to disturbed mitotic progression and aberrant mitosis.
  • Administration of miR-210 mimic reduced tumor formation in a metastatic mouse model.

Conclusions:

  • MiR-210 disrupts mitosis by directly targeting multiple genes crucial for mitotic progression.
  • These findings highlight a potential inhibitory role of miR-210 in tumor formation, suggesting its therapeutic relevance.

More Related Videos

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

Combining Mitotic Cell Synchronization and High Resolution Confocal Microscopy to Study the Role of Multifunctional Cell Cycle Proteins During Mitosis08:33

Combining Mitotic Cell Synchronization and High Resolution Confocal Microscopy to Study the Role of Multifunctional Cell Cycle Proteins During Mitosis

Published on: December 5, 2017

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...